Notch signaling and the developing skeleton

Advances in Experimental Medicine and Biology

Volumn 727, Issue , 2012, Pages 114-130

  Mead, Timothy J ^a   Yutzey, Katherine E ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH RECEPTOR;

ALAGILLE SYNDROME; ARTICLE; BONE CHARACTERISTICS AND FUNCTIONS; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROGENESIS; DEVELOPMENTAL STAGE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; JARCHO LEVIN SYNDROME; MORPHOGENESIS; NONHUMAN; OSTEOBLASTOGENESIS; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOSARCOMA; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; SCLEROTOME; SIGNAL TRANSDUCTION; SKELETON MALFORMATION; SOMITE; SOMITOGENESIS; ANIMAL; BONE; BONE DISEASE; CYTOLOGY; METABOLISM; PATHOLOGY; REVIEW;

ANIMALS; BONE AND BONES; BONE DISEASES; HUMANS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 84859509754     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-0899-4_9     Document Type: Article

References (85)

1. de Crombrugghe B, Lefebvre V, Behringer RRet al. Transcriptional mechanisms ofchondrocyte differentiation. Matrix Biol 2000; 19(5):389-394.
2. de Crombrugghe B, Lefebvre V, Nakashima K. Regulatory mechanisms in the pathways of cartilage and bone formation. Cun Opin Cell Biol 2001; 13(6):721-727.
3. Kovall RA. More complicated than it looks: Assembly of Notch pathway transcription complexes. Oncogene 2008; 27(38):5099-5 109.
4. Iso T, Kedes L, Hamamori Y. HES and HERP families: Multiple effectors of the Notch signaling pathway. J Cell Physiol 2003; 194(3):237-255.
5. Shifley ET, Cole SE. The vertebrate segmentation clock and its role in skeletal birth defects. Birth Defects Res C Embryo Today 2007; 81(2):121-133.
6. Gridley T. The long and short of it: Somite formation in mice. Dcv Dyn. 2006; 235(9):2330-2336.
7. SewellW, Kusumi K. Genetic analysis ofmolecular oscillators inmammalian somitogenesis: Clues for studies of human vertebral disorders. Birth Defects Res C Embryo Today 2007; 81(2):111-120.
8. Conlon RA, Reaume AG, Rossant J. Notchl is required for the coordinate segmentation of somites. Development 1995; 121(5):1533-1545.
9. Huppert SS, Le A, Schroeter EH et al. Embryonic lethality in mice homozygous for a processing-deficient allele ofNotchl. Nature 2000; 405(6789):966-970.
10. Oka C, Nakano T, Wakeham A. et al. Disruption of the mouse RBP-J kappa gene results in early embryonic death. Development 1995; 121(l0):3291-3301.
11. Donoviel DB, Hadjantonakis AK, Ikeda Metal. Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dcv 1999; 13(21):2801-2810.
12. Koizumi K, Nakajima M, Yuasa Set al. The role ofpresenilin 1 during somite segmentation. Development 2001; 128(8):1391-1402.
13. Saga Y, Hata N, Koseki H et al. Mesp2: A novel mouse gene expressed in the presegmented mesoderm and essential for segmentation initiation. Genes Dcv 1997; 11(14):1827-1839.
14. Saga Y. Genetic rescue of segmentation defect in MesP2-deficient mice by MesPl gene replacement. Mech Dcv 1998; 75(1-2):53-66.
15. Hrabe de Angelis M, McIntyre J, 2nd, Gossler A. Maintenance of somite borders in mice requires the Delta homologue Dill. Nature 1997; 386(6626):717-721.
16. Kusumi K, Sun ES, Kerrebrock AW et al. The mouse pudgy mutation disrupts Delta homologue D113 and initiation of early somite boundaries. Nat Genet 1998;19(3):274-278.
17. Zhang N, Gridley T. Defects in somite formation in lunatic fringe-deficient mice. Nature 1998; 394(6691):374-377.
18. Evrard YA, Lun Y, Aulehla A et al. lunatic fringe is an essential mediator of somite segmentation and patterning. Nature 1998; 394(6691):377-381.
19. Bessho Y, Sakata R, Komatsu S et al. Dynamic expression and essential functions of Hes7 in somite segmentation. Genes Dcv 2001; 1 5(20):2642-2647.
20. Nakagawa O, Nakagawa M, Richardson JA et al. HRT1, HRT2 and HRT3: A new subclass of bHLH transcription factors marking specific cardiac, somitic and pharyngeal arch segments. Dcv Biol 1999; 216(1):72-84.
21. Fischer A, Schumacher N, Maier Metal. The Notch target genes Hey 1 and Hey2 are required for embryonic vascular development. Genes Dcv 2004; 18(8):901-911.
22. Leitges M, Neidhardt L, Haenig B et al. The paired homeobox gene Uncx4. 1 specifies pedicles, transverse processes and proximal ribs of the vertebral colunm. Development 2000; 12701):2259-2267.
23. Mead TJ, Yutzey KE. Notch pathway regulation of chondrocyte differentiation and proliferation during appendicular and axial skeleton development. Proc Natl Acad Sci USA 2009; 106(34):14420-14425.
24. Lefebvre V, Smits P. Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res C Embryo Today 2005; 75(3):200-212.
25. Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Dcv Cell 2002; 2(4):389-406.
26. Hunziker EB, Schenk RK, Cruz-Orive LM. Quantitation of chondrocyte performance in growth-plate cartilage during longitudinal bone growth. J Bone Joint Surg Am 1987; 69(2): 162-173.
27. Shum L, Coleman CM, Hatakeyama Y et al. Morphogenesis and dysmorphogenesis of the appendicular skeleton. Birth Defects Res C Embryo Today 2003; 69(2):102-122.
28. Gerber HP, Vu TH, Ryan AM et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999; 5(6):623-628.
29. Kronenberg HM. Developmental regulation of the growth plate. Nature 2003; 423(6937):332-336.
30. WatanabeN, TezukaY, Matsuno Ket al. Suppressionofdifferentiationandproliferationofearly chondrogenic cells by Notch. J Bone Miner Metab 2003; 21(6):344-352.
31. Nakanishi K, Chan YS, Ito K. Notch signaling is required for the chondrogenic specification of mouse mesencephalic neural crest cells. Mech Dcv 2007; 124(3):190-203.
32. Fujimaki R, Toyama Y, Hozumi Net al. Involvement of Notch signaling in initiation of prechondrogenic condensation and nodule formation in limb bud micromass cultures. J Bone Miner Metab 2006; 24(3):191-198.
33. DongY, JesseAM, KohnAetal. RBPj {kappa}-dependentNotch signalingregulatesmesenchymalprogenitor cellproliferation and differentiation during skeletal development. Development 2010; 137(9): 1461-1471.
34. Oldershaw RA, Tew SR, Russell AM et al. Notch signaling through Jagged-i is necessary to initiate chondrogenesis inhumanbone manow stromal cells butmustbe switched offto complete chondrogenesis. Stem Cells 2008; 26(3):666-674.
35. Akiyama H, Chaboissier MC, Martin JF et al. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of SoxS and Soxo. Genes Dcv 2002; 16(21):2813-2828.
36. Grogan SP, 0lcc T, Hiraoka K et al. Repression of chondrogenesis through binding of notch signaling proteins HES-i and HEY-i to N-box domains in the COL2A1 enhancer site. Arthritis Rheum 2008; 58(9):2754-2763.
37. Crowe R, Zikherman J, Niswander L. Delta-i negatively regulates the transition from prehypertrophic to hypertrophic chondrocytes during cartilage formation. Development 1999; 126(5):987-998.
38. Hilton MJ, Tu X, Wu X et al. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat Med 2008; 14(3):306-3 14.
39. KarlssonC, Brantsing C, KageyamaRet al. HES1 andHES5 AreDispensable forCartilage andEndochondral Bone Formation. Cells Tissues Organs 2010.
40. Deng ZL, SharffKA, Tang Net al. Regulation of osteogenic differentiation during skeletal development. Front Biosci 2005; 13:2001-2021.
41. Akiyama H, Kim JE, Nakashima K et al. Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. Proc Natl Acad Sci USA 2005; 102(40:14665-14670.
42. Shindo K, Kawashima N, Sakamoto K et al. Osteogenic differentiation of the mesenchymal progenitor cells, Kusa is suppressed by Notch signaling. Exp Cell Res 2003; 290(2):370-380.
43. Sciaudone M, Gazzeno E, Priest L et al. Notch 1 impairs osteoblastic cell differentiation. Endocrinology 2003; 14402):5631-5639.
44. Zamurovic N, Cappellen D, Rohner D et al. Coordinated activation of notch, Wnt and transforming growth factor-beta signaling pathways in bone morphogenic protein 2-induced osteogenesis. Notch target gene Heyl inhibitsmineralizationandRunx2transcriptionalactivity. JBiolChem2004; 279(36):37704-3771 5.
45. Zanotti S, Smerdel-Ramoya A, Stadmeyer L et al. Notch inhibits osteoblast differentiation and causes osteopenia. Endocrinology 2008; 149(8):3890-3899.
46. Deregowski V, Gazzeno E, Priest Let al. Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt beta-catenin but not bone morphogenetic protein signaling. J Biol Chem 2006; 28 1(10):6203-6210.
47. Engin F, Yao Z, Yang T et al. Dimorphic effects of Notch signaling in bone homeostasis. Nat Med 2008; 14(3):299-305.
48. Ducy P, Zhang R, Geoffroy V et al. Osf2 Cbfai: A transcriptional activator of osteoblast differentiation. Cell 1997; 89(5):747-754.
49. Otto F, Thornell AP, Crompton T et al. Cbfal, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997; 89(5):765-771.
50. Komori T, Yagi H, Nomura S et al. Targeted disruption ofCbfal results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997; 89(5):755-764.
51. Tezuka K, Yasuth M, Watanabe Net al. Stimulation of osteoblastic cell differentiation by Notch. J Bone Miner Res 2002; 17(2):231-239.
52. Nobta M, Tsukazaki T, ShibataY et al. Criticalregulationofbone morphogenetic protein-inducedosteoblastic differentiation by Deltal Jaggedl-activated Notchl signaling. J Biol Chem 2005; 280(16): 15842-15848.
53. Teitelbaum SL, Ross FP. Genetic regulation of osteoclast development and function. Nat Rev Genet 2003; 4(8):638-649.
54. Yoshida H, Hayashi S, Kunisada T et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990; 345(6274):442-444.
55. Simon WS, Lacey DL, Dunstan CR et al. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 1997; 89(2):309-319.
56. Yamada T, Yamazaki H, Yamane T et al. Regulation of osteoclast development by Notch signaling directed to osteoclast precursors and through stromal cells. Blood 2003; 101(6):2227-2234.
57. Bai S, Kopan R, Zou Wet al. NOTCH1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblast lineage cells. J Biol Chem 2008; 283(10):6509-6518.
58. Fukushima H, Nakao A, Okamoto F et al. The association of Notch2 and NF-kappaB accelerates RANKL-induced osteoclastogenesis. Mol Cell Biol 2008; 28(20):6402-6412.
59. Turnpenny PD, Alman B, Cornier AS et al. Abnormal vertebral segmentation and the notch signaling pathway in man. Dcv Dyn 2007; 236(6):1456-1474.
60. Bulman MP, Kusumi K, Frayling TM et al. Mutations in the human delta homologue, DLL3, cause axial skeletal defects in spondylocostal dysostosis. Nat Genet 2000; 24(4):438-441.
61. Dunwoodie SL, Clements M, SparrowDB etal. Axial skeletal defects caused by mutation inthe spondylocostal dysplasia pudgy gene D113 are associated with disruption ofthe segmentation clock within the presomitic mesoderm. Development 2002; 129(7): 1795-1806.
62. Whittock NV, Sparrow DB, Wouters MA et al. Mutated MESP2 causes spondylocostal dysostosis in humans. Am J Hum Genet 2004; 74(6):1249-1254.
63. Sparrow DB, Chapman G, Wouters MA et al. Mutation of the LUNATIC FRINGE gene in humans causes spondylocostal dysostosis with a severe vertebral phenotype. Am J Hum Genet 2006; 78(1):28-37.
64. Sparrow DB, Guillen-Navano E, Fatkin D et al. Mutation of Hairy-and-Enhancer-of-Split-7 in humans causes spondylocostal dysostosis. Hum Mol Genet 2008; 17(23):3761-3766.
65. Sparrow DB, Sillence D, Wouters MA et al. Two nove1 missense mutations in HAIRY-ANDENHANCER-OF-SPLIT-7 in a family with spondylocostal dysostosis. Em J Hum Genet 2010.
66. Loomes KM, Stevens SA, O'Brien ML et al. Dll3 and Notchl genetic interactions model axial segmental and craniofacial malformations of human birth defects. Dcv Dyn 2007; 236(10):2943-2951.
67. MoralesAV, YasuthY, Ish-Horowicz D. Periodic Lunatic fringe expressionis controlled during segmentation by a cyclic transcriptional enhancer responsive to notch signaling. Dcv Cell 2002; 3(1):63-74.
68. Li L, Krantz ID, Deng Yet al. Alagille syndrome is caused by mutations in human Jagged 1, which encodes a ligand for Notchi. Nat Genet 1997; 16(3):243-251.
69. Ellcahloun AG, Pike BL et al. Mutations in the human Jaggedi gene are responsible for Alagille syndrome. Nat Genet 1997; 16(3):235-242.
70. Gridley T. Notch signaling and inherited disease syndromes. Hum Mol Genet 2003; 12 Spec No 1:R9-13. 71.
71. McDaniell R, War hen DM, Sanchez-Lara PA et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am J Hum Genet 2006; 79(1):169-173.
72. Olsen IE, Ittenbach RF, Rovner AJ et al. Deficits in size-adjusted bone mass in children with Alagille syndrome. J Pediatr Gastroenterol Nutr 2005; 40(1):76-82.
73. Xue Y, Gao X, Lindsell CE et al. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jaggedi. Hum Mol Genet 1999; 8(5):723-730.
74. McCright B, Lozier J, Gridley T. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jagi haploinsufficiency. Development 2002; 129(4): 1075-1082.
75. Ishii H, Nakazawa M, Yoshino S et al. Expression of notch homologues in the synovium of rheumatoid arthritis and osteoarthritis patients. Rheumatol Int 2001; 21(1):10-14.
76. KarlssonC, Brantsing C, Egell Set al. Notchi, Jaggedi and HESS are abundantly expressedinosteoarthritis. Cells Tissues Organs 2008; 188(3):287-298.
77. Khan IM, Palmer EA, Archer CW. Fibroblast growth factor-2 induced chondrocyte cluster formation in experimentally wounded articular cartilage is blocked by soluble Jagged-i. Osteoarthritis Cartilage 2010; 18(2):208-219.
78. Engin F, Bertin T, Ma O et al. Notch signaling contributes to the pathogenesis of human osteosarcomas. Hum Mol Genet 2009; 18(8):1464-1470.
79. Zhang P, Yang Y, Zweidler-McKay PA et al. Critical role of notch signaling in osteosarcoma invasion and metastasis. Clin Cancer Res 2008; 14(10):2962-2969.
80. Tanaka M, Setoguchi T, Hirotsu M et al. Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation. Br J Cancer 2009; 100(12):1957-1965.
81. Zhang P, Yang Y, Nob R et al. Regulation of NOTCH signaling by reciprocal inhibition of HES 1 and Deltex 1 and its role in osteosarcoma invasiveness. Oncogene 2010; 29(20):2916-2926.
82. Hughes DP. How the NOTCH Pathway Contributes to the Ability of Osteosarcoma Cells to Metastasize. Cancer Treat Res 2010; 152:479-496.
83. Nakamura E, Nguyen MT, Mackem S. Kinetics of tamoxifen-regulated Crc activity in mice using a cartilage-specific CreER(T) to assay temporal activity windows along the proximodistal limb skeleton. Dcv Dyn 2006; 235(9):2603-2612.
84. Kamiya N, Ye L, Kobayashi T et al. BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. Development 2008; 135(22):3801-3811.
85. Kawanami A, Matsushita T, Chan YY et al. Mice expressing QJFP and CreER in osteochondro progenitor cells in the periosteum. Biochem Biophys Res Commun 2009; 386(3):477-482.